-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 17/09/25 )
NAV
₹30.9
Last change
₹-0.05 -0.0%
Fund Size (AUM)
1308.56 Cr
Performance
18.24% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 17/09/25
AUM
1308.56 Cr
Expense Ratio
2.1 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | -1.76% | 24.39% | 18.24% |
| Nifty Pharma TR INR | 1.03% | 23.76% | 18.86% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.94% |
Cipla Ltd |
6.92% |
Apollo Hospitals Enterprise Ltd |
5.15% |
HealthCare Global Enterprises Ltd |
4.85% |
Lupin Ltd |
4.79% |
Torrent Pharmaceuticals Ltd |
4.58% |
Aster DM Healthcare Ltd Ordinary Shares |
4.4% |
Alkem Laboratories Ltd |
4.31% |
Max Healthcare Institute Ltd Ordinary Shares |
4.05% |
Divi's Laboratories Ltd |
3.9% |
Sector Allocation
Healthcare |
96.92% |
Financial |
1.6% |
Basic Materials |
1.48% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.66% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.96% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
18.28% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
18.28% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
18.28% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.98% (5Y)
-
